Interleukin-6 plasma levels are modulated by a polymorphism in the NF-?B1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.
Leukemia & lymphoma 2012 Mar 53 (3): 411-6.
Giachelia Manuela, Voso Maria Teresa, Tisi Maria Chiara, Martini Maurizio, Bozzoli Valentina, Massini Giuseppina, D'Aló Francesco, Larocca Luigi Maria, Leone Giuseppe, Hohaus Stef
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: